3025473-38-2
Chemical Structure
BLD1102
- CAS No.: 3025473-38-2
- Formula:C76H111N11O33
- Molecular Weight:1706.75
InChIKey: IKDWEDWBIZKAQL-NSRFKTNQSA-N
SMILES: O=C(CCOCC(COCCC(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)=O)(COCCC(NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)=O)NC(CC[C@H](NC(CCCCCN1C(C=CC1=O)=O)=O)C(N[C@@H](C(C)C)C(N[C@@H](C)C(NC2=CC=C3C4=C2OCCC4=C(CN5C6=O)C(C5=CC([C@@](CC)7O)=C6COC7=O)=N3)=O)=O)=O)=O)NC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
Biological Activity: BLD1102 is a linker-load conjugate (Drug-Linker Conjugates for ADC) consisting of a DNA topoisomerase I inhibitor BCPT02 and a protease-cleavable linker. BLD1102 can be used to synthesize ADCs. BLD1102 can be used in cancer research[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BLD1102 | 99.70% | BLD1102 is a linker-load conjugate (Drug-Linker Conjugates for ADC) consisting of a DNA topoisomerase I inhibitor BCPT02 and a protease-cleavable linker. BLD1102 can be used to synthesize ADCs. BLD1102 can be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
